SeaStar Medical is trading down 7.4% now at $3.11 after mixed second-quarter results. - Revenue reached $615,000, increasing 82% year over year, while the company reaffirmed approximately $2 million in 2026 revenue guidance. - The $3.7 million net loss, higher operating expenses and cash declining to $7 million tempered the growth story. - Shares had risen sharply the preceding week before falling 8.94% on August 12; profit-taking may be amplifying the post-earnings reaction. No separate major announcement was identified for August 13, 2026.